MRK - FDA approves Keytruda/Padcev combo therapy for bladder cancer
2023-12-15 18:20:05 ET
More on Merck, Pfizer, etc.
- Pfizer: Dividend Boost At The Right Time
- Pfizer 2024 Guidance - Relentless COVID Pain Isn't Over
- Johnson & Johnson Vs. Pfizer: Better Pharma Stock?
- Merck gets FDA approval for kidney cancer drug Welireg
- AbbVie, Amgen among firms targeted for latest Medicare inflation penalties
For further details see:
FDA approves Keytruda/Padcev combo therapy for bladder cancer